Retrospective single-center cohort study confirming efficacy and safety outcomes of atezolizumab plus chemotherapy in advanced SCLC, replicating key endpoints from the pivotal IMpower133 trial in a real-world population.
A narrative review synthesizing Phase 3 RCT evidence, real-world studies, and FDA analyses to provide practical clinical recommendations on ribociclib use in elderly and frail patients, rather than reporting a new primary trial result.
A single clinical case report without control group, quantified outcomes, or generalizable evidence on the effectiveness of combined treatment for adrenal metastases from colorectal cancer.